Fidelis Capital Partners’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$209K Buy
1,751
+15
+0.9% +$1.97K 0.01% 479
2025
Q4
$236K Hold
1,736
0.02% 439
2025
Q3
$256K Buy
1,736
+43
+3% +$5.96K 0.02% 411
2025
Q2
$243K Buy
+1,693
New +$205K 0.02% 386
2025
Q1
Sell
-1,718
Closed -$211K 462
2024
Q4
$211K Sell
1,718
-245
-12% -$31K 0.02% 412
2024
Q3
$259K Sell
1,963
-134
-6% -$17.9K 0.03% 341
2024
Q2
$266K Sell
2,097
-191
-8% -$26K 0.04% 305
2024
Q1
$296K Buy
2,288
+42
+2% +$5.08K 0.04% 291
2023
Q4
$257K Buy
+2,246
New +$224K 0.06% 274

Other funds holding XYL

Fidelis Capital Partners's XYL Position: Q1 2026 in Review

Fidelis Capital Partners increased its Xylem (XYL) stake by 0.86% in Q1 2026, buying an estimated $1.97K and bringing the position to 1,751 shares worth $209K. The position accounts for 0.01% of the portfolio, ranked #479.

Fidelis Capital Partners first reported a position in XYL in Q4 2023 and has held it in 9 quarters since. The position peaked at $296K in Q1 2024. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Fidelis Capital Partners held 1,751 shares of Xylem worth $209K as of Q1 2026.
  • Fidelis Capital Partners bought 15 Xylem shares in Q1 2026, an estimated $1.97K.
  • Xylem made up 0.01% of Fidelis Capital Partners's portfolio in Q1 2026, its #479 holding.
  • Fidelis Capital Partners first reported a position in Xylem in Q4 2023 and has held it in 9 quarters since.
  • Fidelis Capital Partners's Xylem position peaked at $296K in Q1 2024.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.